UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $272,000 | -43.8% | 14,492 | -44.2% | 0.04% | -34.0% |
| Q2 2022 | $484,000 | -3.0% | 25,967 | -5.9% | 0.05% | 0.0% |
| Q1 2022 | $499,000 | +20.0% | 27,607 | +37.5% | 0.05% | +20.5% |
| Q4 2021 | $416,000 | -31.1% | 20,079 | +6.5% | 0.04% | -34.3% |
| Q3 2021 | $604,000 | +9.0% | 18,858 | +4.9% | 0.07% | +9.8% |
| Q2 2021 | $554,000 | -36.3% | 17,975 | -30.4% | 0.06% | -53.1% |
| Q1 2021 | $870,000 | +45.0% | 25,815 | +55.5% | 0.13% | +21.5% |
| Q4 2020 | $600,000 | +76.0% | 16,603 | +79.3% | 0.11% | +50.7% |
| Q3 2020 | $341,000 | +1.2% | 9,259 | +11.9% | 0.07% | -1.4% |
| Q2 2020 | $337,000 | -18.2% | 8,275 | +13.6% | 0.07% | -33.9% |
| Q1 2020 | $412,000 | -0.7% | 7,285 | +8.7% | 0.11% | +11.2% |
| Q4 2019 | $415,000 | – | 6,699 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |